Cognis Nutrition & Health is further expanding its successful Super Xangold® product line with new 10% beadlets. Super Xangold®, the only health ingredient with a 5 to 1 ratio of natural lutein esters and zeaxanthin esters, is known for providing The Gold Standard™ in eye health benefits.
Super Xangold® contains the same 5 to 1 ratio of lutein esters and zeaxanthin esters found in natural dietary sources. It is patent protected by U.S. Patent #6,191,293 and EU Patent #EP1073694B1, providing manufacturers assurance that their product will be unique to the marketplace. The new Super Xangold® 10% beadlets give manufacturers the flexibility to market soft gels or a more economical tablet form, with either product delivering exceptional quality, performance and ease of use. Super Xangold® offers the precise ratio of eye health ingredients and reduces the need for additional blending or mixing during processing.
Now, recent scientific studies are demonstrating that these ingredients also can deliver beauty benefits through nutrition. Adding lutein and zeaxanthin can help producers capitalize on the global trend of “Beauty from Within.” Based on clinical evidence, the following claims may be possible for lutein:
• Helps improves skin hydration and elasticity
• Improves skin moisture
• Helps reduce UV damage from sunlight
• Helps to maintain your skin’s healthy look and feel
“The new Super Xangold® 10% is an excellent complement to the oil we launched last year at SupplySide West,” said Rob Bailey, Marketing Manager, Cognis Nutrition & Health. “We are pleased to offer customers a range of ingredient forms best suited for their applications including beadlets with superior tableting characteristics and oils with proven stability. Whether they are promoting beauty from within or eye health, Super Xangold® provides compelling benefits that can be packaged with a natural message.” Mr. Bailey explained that products containing Super Xangold® may use a natural label claim since the natural lutein esters are obtained from marigold flowers using a mild extraction process.
About Super Xangold®
Super Xangold® is a highly bioavailable source of lutein and appeals to manufacturers for its stability and long-lasting potency. Xangold® is extracted from marigold flowers grown specifically for Cognis and is available as oils and beadlets. Scientific studies have consistently shown that lutein from lutein esters has equivalent bioavailability, and may be even superior to that of free lutein. The Super Xangold® product line offers non-GMO, kosher and vegetarian-source lutein esters for a variety of product applications. Xangold® was the first source of lutein to complete the FDA GRAS notification process in January 2003.
For information in North America about Super Xangold® natural lutein esters and zeaxanthin esters, please call 800-673-3702 to place an order, e-mail [email protected], or fax 513.482.3576.
Cognis (www.cognis.com) is a worldwide supplier of innovative specialty chemicals and nutritional ingredients, with a particular focus on the areas of wellness and sustainability. The company employs about 7,600 people, and it operates production sites and service centers in 30 countries. Cognis has dedicated its activities to a high level of sustainability and delivers natural source raw materials and ingredients for food, nutrition and healthcare markets, and the cosmetics, detergents and cleaners industries. Another main focus is on products for a number of other industries, such as coatings and inks, lubricants, as well as agriculture and mining.
Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and SV Life Sciences. In 2007, Cognis recorded sales of about 3.52 billion euros and an Adjusted EBITDA (operating result) of 410 million euros.